skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 227  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Material Type:
Article
Add to My Research

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

The New England journal of medicine, 2017-05, Vol.376 (18), p.1713-1722 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;info:eu-repo/semantics/openAccess ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1615664 ;PMID: 28304224

Full text available

2
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Material Type:
Article
Add to My Research

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

The Lancet (British edition), 2017-04, Vol.389 (10077), p.1399-1409 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 8, 2017 ;2017. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)30069-7 ;PMID: 28237263

Full text available

3
Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus
Material Type:
Article
Add to My Research

Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus

Nature reviews. Endocrinology, 2020-10, Vol.16 (10), p.556-577 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;ISSN: 1759-5029 ;ISSN: 1759-5037 ;EISSN: 1759-5037 ;DOI: 10.1038/s41574-020-0392-2 ;PMID: 32855502

Full text available

4
Pharmacodynamics, Efficacy and Safety of Sodium–Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Material Type:
Article
Add to My Research

Pharmacodynamics, Efficacy and Safety of Sodium–Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus

Drugs (New York, N.Y.), 2015-01, Vol.75 (1), p.33-59 [Peer Reviewed Journal]

Springer International Publishing Switzerland 2014 ;Copyright Springer Science & Business Media Jan 2015 ;ISSN: 0012-6667 ;ISSN: 1179-1950 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-014-0337-y ;PMID: 25488697

Full text available

5
Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease
Material Type:
Article
Add to My Research

Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease

Diabetes & metabolism, 2018-12, Vol.44 (6), p.457-464 [Peer Reviewed Journal]

2018 Elsevier Masson SAS ;Copyright © 2018 Elsevier Masson SAS. All rights reserved. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2018.09.005 ;PMID: 30266577

Full text available

6
Metformin and COVID-19: From cellular mechanisms to reduced mortality
Material Type:
Article
Add to My Research

Metformin and COVID-19: From cellular mechanisms to reduced mortality

Diabetes & metabolism, 2020-11, Vol.46 (6), p.423-426 [Peer Reviewed Journal]

2020 Elsevier Masson SAS ;Copyright © 2020 Elsevier Masson SAS. All rights reserved. ;2020 Elsevier Masson SAS. All rights reserved. 2020 Elsevier Masson SAS ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2020.07.006 ;PMID: 32750451

Full text available

7
Weight management in type 2 diabetes: current and emerging approaches to treatment
Material Type:
Article
Add to My Research

Weight management in type 2 diabetes: current and emerging approaches to treatment

Diabetes care, 2015-06, Vol.38 (6), p.1161-1172 [Peer Reviewed Journal]

2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Jun 2015 ;ISSN: 0149-5992 ;ISSN: 1935-5548 ;EISSN: 1935-5548 ;DOI: 10.2337/dc14-1630 ;PMID: 25998297 ;CODEN: DICAD2

Full text available

8
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
Material Type:
Article
Add to My Research

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

The New England journal of medicine, 2010-09, Vol.363 (10), p.905-917 [Peer Reviewed Journal]

Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1003114 ;PMID: 20818901 ;CODEN: NEJMAG

Full text available

9
Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
Material Type:
Article
Add to My Research

Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

The New England journal of medicine, 2010-04, Vol.362 (16), p.1477-1490 [Peer Reviewed Journal]

Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2010 Massachusetts Medical Society ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1001121 ;PMID: 20228403 ;CODEN: NEJMAG

Full text available

10
Pharmacokinetic and Pharmacodynamic Profile of Empagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor
Material Type:
Article
Add to My Research

Pharmacokinetic and Pharmacodynamic Profile of Empagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor

Clinical pharmacokinetics, 2014-03, Vol.53 (3), p.213-225 [Peer Reviewed Journal]

The Author(s) 2014 ;2015 INIST-CNRS ;Copyright Wolters Kluwer Health Adis International Mar 2014 ;ISSN: 0312-5963 ;ISSN: 1179-1926 ;EISSN: 1179-1926 ;DOI: 10.1007/s40262-013-0126-x ;PMID: 24430725 ;CODEN: CPKNDH

Full text available

11
Antidiabetic agents and risk of atrial fibrillation/flutter: A comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists
Material Type:
Article
Add to My Research

Antidiabetic agents and risk of atrial fibrillation/flutter: A comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists

Diabetes & metabolism, 2022-11, Vol.48 (6), p.101390-101390, Article 101390 [Peer Reviewed Journal]

2022 Elsevier Masson SAS ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2022.101390 ;PMID: 36170946

Full text available

12
Lower limb amputations: protection with GLP-1 receptor agonists rather than increased risk with SGLT2 inhibitors?
Material Type:
Article
Add to My Research

Lower limb amputations: protection with GLP-1 receptor agonists rather than increased risk with SGLT2 inhibitors?

Diabetes & metabolism, 2022-03, Vol.48 (2), p.101325-101325, Article 101325 [Peer Reviewed Journal]

2022 Elsevier Masson SAS ;Copyright © 2022 Elsevier Masson SAS. All rights reserved. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2022.101325 ;PMID: 35121148

Full text available

13
Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events
Material Type:
Article
Add to My Research

Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events

The New England journal of medicine, 2010-04, Vol.362 (16), p.1463-1476 [Peer Reviewed Journal]

Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2010 Massachusetts Medical Society ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1001122 ;PMID: 20228402 ;CODEN: NEJMAG

Full text available

14
DPP-4 inhibition and COVID-19: From initial concerns to recent expectations
Material Type:
Article
Add to My Research

DPP-4 inhibition and COVID-19: From initial concerns to recent expectations

Diabetes & metabolism, 2021-03, Vol.47 (2), p.101213-101213, Article 101213 [Peer Reviewed Journal]

2020 Elsevier Masson SAS ;Copyright © 2020 Elsevier Masson SAS. All rights reserved. ;2020 Elsevier Masson SAS. All rights reserved. 2020 Elsevier Masson SAS ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2020.11.005 ;PMID: 33249199

Full text available

15
Pharmacokinetic/Pharmacodynamic Properties and Clinical Use of SGLT2 Inhibitors in Non-Asian and Asian Patients with Type 2 Diabetes and Chronic Kidney Disease
Material Type:
Article
Add to My Research

Pharmacokinetic/Pharmacodynamic Properties and Clinical Use of SGLT2 Inhibitors in Non-Asian and Asian Patients with Type 2 Diabetes and Chronic Kidney Disease

Clinical pharmacokinetics, 2020-08, Vol.59 (8), p.981-994 [Peer Reviewed Journal]

Springer Nature Switzerland AG 2020 ;Copyright Springer Nature B.V. Aug 2020 ;ISSN: 0312-5963 ;ISSN: 1179-1926 ;EISSN: 1179-1926 ;DOI: 10.1007/s40262-020-00885-z ;PMID: 32201911

Full text available

16
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies
Material Type:
Article
Add to My Research

Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies

Diabetes & metabolism, 2021-11, Vol.47 (6), p.101220-101220, Article 101220 [Peer Reviewed Journal]

2020 Elsevier Masson SAS ;Copyright © 2020 Elsevier Masson SAS. All rights reserved. ;2020 Elsevier Masson SAS. All rights reserved. 2020 Elsevier Masson SAS ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2020.101220 ;PMID: 33359486

Full text available

17
Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trials
Material Type:
Article
Add to My Research

Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trials

Diabetes & metabolism, 2020-06, Vol.46 (3), p.186-196 [Peer Reviewed Journal]

2020 Elsevier Masson SAS ;Copyright © 2020 Elsevier Masson SAS. All rights reserved. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2020.01.002 ;PMID: 32007623

Full text available

18
Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control
Material Type:
Article
Add to My Research

Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control

Diabetes & metabolism, 2015-06, Vol.41 (3), p.183-194 [Peer Reviewed Journal]

2015 ;Copyright © 2015. Published by Elsevier Masson SAS. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2015.02.003 ;PMID: 25794703

Full text available

19
When therapeutic drugs lead to diabetes
Material Type:
Article
Add to My Research

When therapeutic drugs lead to diabetes

Diabetologia, 2022-05, Vol.65 (5), p.751-762 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 ;2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0012-186X ;ISSN: 1432-0428 ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-022-05666-w ;PMID: 35244742

Full text available

20
Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review
Material Type:
Article
Add to My Research

Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review

Diabetes & metabolism, 2024-03, Vol.50 (2), p.101508-101508, Article 101508 [Peer Reviewed Journal]

2023 ;Copyright © 2023. Published by Elsevier Masson SAS. ;ISSN: 1262-3636 ;ISSN: 1878-1780 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2023.101508 ;PMID: 38158077

Full text available

Results 1 - 20 of 227  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (220)

Refine My Results

Creation Date 

From To
  1. Before 1996  (6)
  2. 1996 To 2003  (19)
  3. 2004 To 2009  (30)
  4. 2010 To 2016  (81)
  5. After 2016  (91)
  6. More options open sub menu

Resource Type 

  1. Web Resources  (125)
  2. Articles  (102)
  3. More options open sub menu

Language 

  1. French  (119)
  2. English  (110)
  3. Japanese  (10)
  4. More options open sub menu

Searching Remote Databases, Please Wait